Health X Platform Limited has informed the Exchange about Intimation under Regulation 30 of SEBI (LODR) Reg, 2015 Completion of the transfer of the entire equity stake of Mitsubishi Corporation held in Sastasundar Healthbuddy Limited, a material subsidiary of Health X Platform Limited (Company), to Envision India Fund.
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 3.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Health X Platform Limited has announced the completion of a stake sale in its material subsidiary Sastasundar Healthbuddy Limited. Mitsubishi Corporation sold its entire holding of 10,13,766 equity shares (4.68% stake) to Envision India Fund. The transaction was completed on May 12, 2026. Following this transfer, Mitsubishi Corporation has ceased to be a shareholder of Sastasundar Healthbuddy Limited. The board of the subsidiary took note of this transfer on May 15, 2026. This follows an earlier disclosure dated February 25, 2026 regarding the execution of a Share Purchase Agreement.
This is a change in the shareholding pattern of the company's material subsidiary. While the 4.68% stake sale by Mitsubishi Corporation does not directly impact the parent company's shareholding, it reflects a strategic restructuring at the subsidiary level with a new investor (Envision India Fund) entering.